Table of Contents
k k Chapter 28: Peptides, Antimalarial, and
k k k k
Chapter 01: Drug Development and
k k k k Anthelmintic
Ethical Considerations
k k Chapter 29: HIV- and AIDS-Related
k k k k
Chapter 02: Pharmacokinetics,
k k Drugs
k
Pharmacodynamics, and
k k Chapter 30: Transplant Drugs
k k k
Pharmacogenetics
k Chapter 31: Vaccines
k k k
Chapter 03: Cultural Considerations
k k k Chapter 32: Anticancer Drugs
k k k k
Chapter 04: Complementary and
k k k k Chapter 33: Targeted Therapies to Treat
k k k k k
Alternative Therapies
k k C ancer
k
Chapter 05: Pediatric Considerations
k k k Chapter 34: Biologic Response
k k k
Chapter 06: Geriatric Considerations
k k k k Modifiers
k
Chapter 07: Drugs in Substance Use
k k k k k k Chapter 35: Upper Respiratory
k k k
Disorder
k Disorders
k
Chapter 08: The Nursing Process and
k k k k k Chapter 36: Lower Respiratory
k k k
Patient-Centered Care
k k Disorders
k
Chapter 09: Safety and Quality
k k k k Chapter 37: Cardiac Glycosides,
k k k
Chapter 10: Drug
k k k Antianginals, and
k k
AdministrationChapter 11: Drug
k k k k AntidysrhythmicsChapter 38:
k k k
Calculations Chapter 12: Fluid
k k k k Diuretics
k
Volume and Electrolytes
k k k Chapter 39: Antihypertensive
k k
Chapter 13: Vitamin and Mineral
k k k k Chapter 40: Anticoagulants,
k k
R eplacement
k Antiplatelets, and Thrombolytics
k k k
Chapter 14: Nutritional Support
k k k Chapter 41: Antihyperlipidemics and
k k k k
Chapter 15: Adrenergic Agonists and
k k k k k Peripheral Vasodilators
k k
Antagonists
k Chapter 42: Gastrointestinal Tract
k k k
Chapter 16: Cholinergic Agonists and
k k k k Disorders
k
Antagonists
k Chapter 43: Antiulcer Drugs
k k k
Chapter 17: Stimulants
k k Chapter 44: Eye and Ear Disorders
k k k k k k
Chapter 18: Depressants
k k Chapter 45: Dermatologic Disorders
k k k k
Chapter 19: Antiseizure Drugs
k k k k Chapter 46: Pituitary, Thyroid,
k k k k
Chapter 20: Drugs for Parkinsonism and
k k k k k Parathyroid, and Adrenal Disorders
k k k k
Alzheimer's Disease
k k Chapter 47: Antidiabetics
k k k
Chapter 21: Drugs for Neuromuscular
k k k k Chapter 48: Urinary Disorders
k k k
Disorders and Muscle Spasms
k k k k Chapter 49: Pregnancy and Preterm
k k k k k
Chapter 22: Antipsychotics and
k k k k Labor
k
Anxiolytics
k Chapter 50: Labor, Delivery, and
k k k k
Chapter 23: Antidepressants and Mood
k k k k Postpartum
k
Stabilizers
k Chapter 51: Neonatal and Newborn
k k k k
Chapter 24: Antiinflammatories
k k Chapter 52: Women's Reproductive
k k k k
Chapter 25: Analgesics
k k H ealth
k
Chapter 26: Antibacterials
k k Chapter 53: Men's Reproductive Health
k k k k
Chapter 27: Antituberculars, Antifungals,
k k k Chapter 54: Sexually Transmitted
k k k k
and Antivirals
k k Infections
k
Chapter 55: Adult and Pediatric
k k k k
,Emergency Drugs
k
, Chapter 01: Drug Development and Ethical Considerations k k k k k k
MULTIPLE CHOICE k
1. The nurse is preparing to administer a schedule II injectable drug and is drawing up half of
k k k k k k k k k k k k k k k k
the contents of a Single-use vial. Which nursing action is correct?
k k k k k k k k k k k
a. Ask another nurse to observe and cosign wasting the remaining drug from the vial.
k k k k k k k k k k k k k
b. Keep the remaining amount in the patient’s drawer to give at the next dose.
k k k k k k k k k k k k k
c. Record the amount unused in the patient’s medication record.
k k k k k k k k
d. Dispose of the vial with the remaining drug into a locked collection box.
k k k k k k k k k k k k
ANS: A
k k
Schedule II drugs are controlled substances, and all must be accounted for. When wasting a
k k k k k k k k k k k k k k
portion of a drug, another nurse should observe and cosign that a drug was wasted.
k k k k k k k k k k k k k k k
DIF: COGNITIVE LEVEL: Applying (Application)
k k k k
kTOP: NURSING PROCESS: Nursing Intervention
k k k k
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
k k k k k k k
2. A patient is prescribed a medication and asks the nurse if the drug is available in a generic
k k k k k k k k k k k k k k k k k
form. The nurse understands that a generic medication will have a name that
k k k k k k k k k k k k k
a. is a registered trademark.
k k k
b. is always capitalized.
k k
c. describes the drugs chemical structure. k k k k
d. is non-proprietary.
k
ANS: D
k k
The generic name is the official, non-proprietary name for a drug. The brand name is the
k k k k k k k k k k k k k k k
ktrademark name and is always capitalized. The chemical name describes the chemical structure
k k k k k k k k k k k k
of the drug.
k k k
DIF: COGNITIVE LEVEL: Understanding (Comprehension)
k k k k
TOP: NURSING PROCESS: N/A
k k k k
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
k k k k k k k
3. A patient receives a prescription on which the provider has noted that a generic
k k k k k k k k k k k k k
kmedicationm ay be given.The patient asks the nurse what this means. What will the nurse tell
k k k k k k k k k k k k k k k
kthe patientabout generic drugs?
k k k k
a. They contain the same inert ingredients as brand-name drugs.
k k k k k k k k
b. They have chemical structures that are identical to proprietary drugs.
k k k k k k k k k
c. They tend to be less expensive than brand-name drugs.
k k k k k k k k
d. They undergo extensive testing before they are
k k k k k k
kmarketed.ANS: C k k
Generic drugs are approved by the FDA if they are proved to be bioequivalent to the brand-
k k k k k k k k k k k k k k k k
kname drug. They tend to be less expensive because manufacturers of these drugs do not have
k k k k k k k k k k k k k k k
to do the extensive testing required of brand-name drugs before marketing. They are not
k k k k k k k k k k k k k k
kidentical to brand-name drugs and often have different inert ingredients.
k k k k k k k k k
DIF: COGNITIVE LEVEL: Applying (Application)
k k k k
TOP: NURSING PROCESS: Nursing Intervention: Patient Teaching
k k k k k k
MSC: NCLEX: Management of Client Care
k k k k k k
4. The nurse reviews information about a drug and notes the initials USP after the drugs official
k k k k k k k k k k k k k k k
name. The nurse understands that this designation indicates the drug
k k k k k k k k k k
a. is a controlled substance.
k k k
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller Ascorers. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $17.99. You're not tied to anything after your purchase.